Rahul R Karamchandani1, Dale Strong2, Jeremy B Rhoten1, Tanushree Prasad2, Jacob Selig1, Gary Defilipp3, Andrew W Asimos4. 1. Neurology, Neurosciences Institute, Atrium Health, Charlotte, USA. 2. Information and Analytics Services, Atrium Health, Charlotte, USA. 3. Charlotte Radiology, Neurosciences Institute, Atrium Health, Charlotte, USA. 4. Emergency Medicine, Neurosciences Institute, Atrium Health, Charlotte, USA.
Abstract
INTRODUCTION: Prognostic factors for functional outcome after basilar artery occlusion (BAO) treated with modern endovascular therapy (EVT) are sparse. We investigated the association between clinical characteristics, readily available imaging variables, and outcome in BAO patients treated with EVT. METHODS: Retrospective analysis from a large healthcare system's prospectively collected code stroke registry of acute BAO patients treated with EVT between January 2017-January 2020. The primary outcome measure was a favorable 90-day modified Rankin score (mRS) of 0-2. RESULTS: 65 patients (median age 67 years, 57% male, median NIHSS 16) met the study inclusion criteria. Thrombolysis in Cerebral Infarction (TICI) 2 b-3 revascularization was achieved in 57/65 patients (88%) with a median time to revascularization of 445 minutes [IQR 302-840]. Ninety-day good outcome was seen in 35% (23/65) of patients. In a univariate analysis, age, history of ischemic stroke, baseline NIHSS, BAO site, and discharge mRS were associated with significant differences between the good and poor outcome groups. A multivariable logistic regression analysis demonstrated an independent association with 90-day good outcome and younger age (per 1-year, OR 0.79, 95% CI 0.64, 0.98) and good discharge mRS (0-2) (OR > 999.99, 95% CI 13.26, > 999.99). CONCLUSIONS: Patients presenting with an acute BAO treated with modern EVT have a good 90-day outcome in over one-third of cases. Age and discharge mRS are independently associated with good 90-day outcome. Additional studies may focus on factors that can enhance discharge function after BAO, a novel prognostic indicator for favorable 90-day outcome in our study.
INTRODUCTION: Prognostic factors for functional outcome after basilar artery occlusion (BAO) treated with modern endovascular therapy (EVT) are sparse. We investigated the association between clinical characteristics, readily available imaging variables, and outcome in BAO patients treated with EVT. METHODS: Retrospective analysis from a large healthcare system's prospectively collected code stroke registry of acute BAO patients treated with EVT between January 2017-January 2020. The primary outcome measure was a favorable 90-day modified Rankin score (mRS) of 0-2. RESULTS: 65 patients (median age 67 years, 57% male, median NIHSS 16) met the study inclusion criteria. Thrombolysis in Cerebral Infarction (TICI) 2 b-3 revascularization was achieved in 57/65 patients (88%) with a median time to revascularization of 445 minutes [IQR 302-840]. Ninety-day good outcome was seen in 35% (23/65) of patients. In a univariate analysis, age, history of ischemic stroke, baseline NIHSS, BAO site, and discharge mRS were associated with significant differences between the good and poor outcome groups. A multivariable logistic regression analysis demonstrated an independent association with 90-day good outcome and younger age (per 1-year, OR 0.79, 95% CI 0.64, 0.98) and good discharge mRS (0-2) (OR > 999.99, 95% CI 13.26, > 999.99). CONCLUSIONS: Patients presenting with an acute BAO treated with modern EVT have a good 90-day outcome in over one-third of cases. Age and discharge mRS are independently associated with good 90-day outcome. Additional studies may focus on factors that can enhance discharge function after BAO, a novel prognostic indicator for favorable 90-day outcome in our study.
Authors: Volker Puetz; Andrei Khomenko; Michael D Hill; Imanuel Dzialowski; Patrik Michel; Christian Weimar; Christine A C Wijman; Heinrich P Mattle; Stefan T Engelter; Keith W Muir; Thomas Pfefferkorn; David Tanne; Kristina Szabo; L Jaap Kappelle; Ale Algra; Ruediger von Kummer; Andrew M Demchuk; Wouter J Schonewille Journal: Stroke Date: 2011-09-29 Impact factor: 7.914
Authors: I Mourand; P Machi; E Nogué; C Arquizan; V Costalat; M-C Picot; A Bonafé; D Milhaud Journal: AJNR Am J Neuroradiol Date: 2014-02-13 Impact factor: 3.825
Authors: Wouter J Schonewille; Christine A C Wijman; Patrik Michel; Christina M Rueckert; Christian Weimar; Heinrich P Mattle; Stefan T Engelter; David Tanne; Keith W Muir; Carlos A Molina; Vincent Thijs; Heinrich Audebert; Thomas Pfefferkorn; Kristina Szabo; Perttu J Lindsberg; Gabriel de Freitas; L Jaap Kappelle; Ale Algra Journal: Lancet Neurol Date: 2009-07-03 Impact factor: 44.182
Authors: M Mahmoudi; C Dargazanli; F Cagnazzo; I Derraz; C Arquizan; A Wacogne; J Labreuche; A Bonafe; D Sablot; P H Lefevre; G Gascou; N Gaillard; C Scott; V Costalat; I Mourand Journal: AJNR Am J Neuroradiol Date: 2020-08-20 Impact factor: 3.825